News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Somatostatin-immunoreactive Cells in Medullary Carcinoma of the Thyroid
- Somatostatin Inhibits the Pentagastrin-Induced Release of Serum Calcitonin in Medullary Carcinoma of the Thyroid
- Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin Analogues
- A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas
- Metastatic Hormone-Refractory Prostatic Adenocarcinoma Expresses Somatostatin Receptors and Is Visualized in Vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide Scintigraphy
- Biology of Somatostatin and Somatostatin Receptors in Breast Cancer
- Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress
- Expression of potential therapeutic target SSTR2a in primary and metastatic non-keratinizing nasopharyngeal carcinoma
- The melatonin action on stromal stem cells within pericryptal area in colon cancer model under constant light
- High somatostatin receptor expression and efficacy of somatostatin analogues in patients with metastatic Merkel cell carcinoma
- Mediation of retinoic acid-induced growth and anti-tumour activity
- Post-treatment Levels of Plasma 25- And 1,25-dihydroxy Vitamin D and Mortality in Men With Aggressive Prostate Cancer
- All-Trans Retinoic Acid Stimulates Viral Mimicry, Interferon Responses and Antigen Presentation in Breast-Cancer Cells
- Modulation of Radiation-induced Base Excision Repair Pathway Gene Expression by Melatonin
- Melatonin: An atypical hormone with major functions in the regulation of angiogenesis
- Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression
- Increased oxidative damage to membrane lipids following surgery for breast cancer
- SPECT-CT Somatostatin-Receptor Scintigraphy in Medullary Thyroid Cancer (MTC)
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Frequently Asked Questions
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Vademecum
- How effective is chemo therapy?
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways